Literature DB >> 26868347

Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.

Matthew S Katz1, Zain A Husain2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26868347     DOI： 10.1016/S1470-2045(16)00026-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.

Authors:  N Tomita; K Okuda; S Osaga; A Miyakawa; R Nakanishi; Y Shibamoto
Journal:  Clin Transl Oncol       Date:  2020-07-23       Impact factor: 3.405

2.  Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.

Authors:  Austin Lammers; Timur Mitin; Drew Moghanaki; Charles R Thomas; Robert Timmerman; Sara E Golden; Sujata Thakurta; Rafal Dziadziuszko; Christopher G Slatore
Journal:  Adv Radiat Oncol       Date:  2018-01-31

3.  Anti-Ly6G binding and trafficking mediate positive neutrophil selection to unleash the anti-tumor efficacy of radiation therapy.

Authors:  Gaël Boivin; Pierre-Benoit Ancey; Romain Vuillefroy de Silly; Pradeep Kalambaden; Caroline Contat; Benoit Petit; Jonathan Ollivier; Jean Bourhis; Etienne Meylan; Marie-Catherine Vozenin
Journal:  Oncoimmunology       Date:  2021-02-08       Impact factor: 8.110
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.